US considering intellectual property waiver for COVID vaccines

The White House said officials were reviewing the most efficient way to maximise global output of vaccines.

This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.

Accept Learn more…